Heron Therapeutics (HRTX) Asset Writedowns and Impairment (2019 - 2026)
Heron Therapeutics (HRTX) recorded Asset Writedowns and Impairment of $7,000 in Q1 2026, up 40.0% from the prior quarter.
Powered by 
Analysis
Heron Therapeutics (HRTX) Asset Writedowns and Impairment (2019 - 2026) Analysis & Trends
For FY2025, Heron Therapeutics reported Asset Writedowns and Impairment of $414,000, down 90.6% from FY2024.
- Annual Asset Writedowns and Impairment has a five-year compound annual growth rate of -13.3% (FY2020 to FY2025).
- Across earlier years, Asset Writedowns and Impairment came in at $4.41 million in FY2024 (+614.6%), $617,000 in FY2023 (+195.2%), $209,000 in FY2022 (-56.3%) and $478,000 in FY2021 (-43.6%).
- Quarterly Asset Writedowns and Impairment has ranged from $5,000 in Q4 2025 to $3.27 million in Q2 2024 over the past five years.
- On a year-over-year basis, Asset Writedowns and Impairment rose in 1 of the last four quarters, with growth averaging 70.4%.
- Peak year-over-year performance for Asset Writedowns and Impairment in the last five years was growth of 437.7% in Q3 2024, against a decline of 96.4% in Q4 2025 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Heron Therapeutics | 66.45 Mn | -123.12 Mn | 26.09 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 7,000.00 |
| Dec 31, 2025 | 5,000.00 |
| Sep 30, 2025 | 409,000.00 |
| Dec 31, 2024 | 140,000.00 |
| Sep 30, 2024 | 828,000.00 |
| Jun 30, 2024 | 3.27 Mn |
| Mar 31, 2024 | 170,000.00 |
| Dec 31, 2023 | 154,000.00 |
| Sep 30, 2023 | 154,000.00 |
| Jun 30, 2023 | 155,000.00 |
| Mar 31, 2023 | 154,000.00 |
| Dec 31, 2022 | 79,000.00 |
| Sep 30, 2022 | 42,000.00 |
| Jun 30, 2022 | 41,000.00 |
| Mar 31, 2022 | 47,000.00 |
| Dec 31, 2021 | 124,000.00 |
| Sep 30, 2021 | 164,000.00 |
| Jun 30, 2021 | 110,000.00 |
| Mar 31, 2021 | 80,000.00 |
| Dec 31, 2020 | 786,000.00 |
API Access
Heron Therapeutics Asset Writedowns and Impairment API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=HRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-writedowns-and-impairment", "ticker": "HRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=HRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();